StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 711.00
0.00 (0.00%)
Oct 26, 2026, 3:30 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 7.16 billion as of October 26, 2026. It is the 30,856th most valuable company in the world and the 2,795th biggest in Japan. Its market cap has decreased by 18.75% in one year.
Market Cap
7.16B
Enterprise Value
5.45B
Revenue
2.81B
Global Rank
Country Rank
#2,795 Japan
PE Ratio
46.32
ChartMarket Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 7.16B, a decrease of -66.16%. That is a compound annual growth rate of -18.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 7.16B | -10.34% |
| Dec 30, 2025 | 7.99B | -39.54% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Carna Biosciences | 8.14B |
| K Pharma,Inc. | 8.10B |
| J-Pharma | 7.80B |
| Kidswell Bio | 7.59B |
| CellSeed | 7.50B |
| Chiome Bioscience | 7.26B |
| Nano Holdings | 6.98B |
| OncoTherapy Science | 6.94B |